A Case of EGFR-mutant Squamous Cell Lung Cancer Treated With Necitumumab Combination Therapy
The combination therapy of cisplatin, gemcitabine, and necitumumab was effective in treating pretreated EGFR-mutant squamous cell lung cancer in this case. It is necessary to accumulate more evidence to determine the most effective treatment for advanced EGFR-mutant squamous cell lung cancer.
Authors
- Seisuke Okazawa (ORCID: https://orcid.org/0000-0002-2592-7131)
- Daisuke Furukawa (ORCID: https://orcid.org/0000-0002-5383-1663)
- Satoshi Nomura (ORCID: https://orcid.org/0000-0002-8678-4234)
- Minehiko Inomata (ORCID: https://orcid.org/0000-0002-6846-187X)
- Naoki Takata (ORCID: https://orcid.org/0000-0002-8479-8165)
- Kotaro Tokui
- Shingo Imanishi
Institutions
- Toyama City Hospital (JP)
- Toyama University Hospital (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-02-26
- DOI
- https://doi.org/10.21873/invivo.13925
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 3.04